{"id":"https://openalex.org/W4313205237","doi":"https://doi.org/10.1021/acs.oprd.2c00323","title":"Control of Hydrogen Fluoride Formation and Release during a Large-Scale Nitroarene Reduction in the Manufacture of AZD9977","display_name":"Control of Hydrogen Fluoride Formation and Release during a Large-Scale Nitroarene Reduction in the Manufacture of AZD9977","publication_year":2022,"publication_date":"2022-12-28","ids":{"openalex":"https://openalex.org/W4313205237","doi":"https://doi.org/10.1021/acs.oprd.2c00323"},"language":"en","primary_location":{"id":"doi:10.1021/acs.oprd.2c00323","doi":"https://doi.org/10.1021/acs.oprd.2c00323","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.2c00323","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059247073","display_name":"Carl J. Mallia","orcid":"https://orcid.org/0000-0003-0218-7019","observed_orcids":["https://orcid.org/0000-0003-0218-7019"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Carl J. Mallia","raw_affiliation_strings":["Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":"https://orcid.org/0000-0003-0218-7019","affiliations":[{"raw_affiliation_string":"Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087564824","display_name":"Joel Le Bars","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jo\u00ebl Le Bars","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112276497","display_name":"Simon Hardy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Hardy","raw_affiliation_strings":["Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087264259","display_name":"Alex L. Lamacraft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alex Lamacraft","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Simon Harding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Harding","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048803046","display_name":"David R. J. Hose","orcid":"https://orcid.org/0000-0003-3872-7996","observed_orcids":["https://orcid.org/0000-0003-3872-7996"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Hose","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035305231","display_name":"Lindsay Snow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lindsay Snow","raw_affiliation_strings":["Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006348509","display_name":"Rebecca C. Poulten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rebecca C. Poulten","raw_affiliation_strings":["Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086026157","display_name":"Benjamin C. Dobson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Benjamin C. Dobson","raw_affiliation_strings":["Clinical Manufacture & Supply, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Manufacture & Supply, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031192801","display_name":"Trevor Churchill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Trevor Churchill","raw_affiliation_strings":["Clinical Manufacture & Supply, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Manufacture & Supply, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031509715","display_name":"Paul M. Gillespie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul M. Gillespie","raw_affiliation_strings":["Clinical Manufacture & Supply, AstraZeneca, MacclesfieldSK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Manufacture & Supply, AstraZeneca, MacclesfieldSK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5059247073"],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.3552,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.46275453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"27","issue":"1","first_page":"167","last_page":"178"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.7240999937057495,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.7240999937057495,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12240","display_name":"Nanomaterials for catalytic reactions","score":0.07530000060796738,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11281","display_name":"Asymmetric Hydrogenation and Catalysis","score":0.07400000095367432,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hydrogen-fluoride-formation","display_name":"hydrogen fluoride formation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/nitroarene-reduction","display_name":"nitroarene reduction","score":0.9819999933242798},{"id":"https://openalex.org/keywords/oxidative-pathway","display_name":"oxidative pathway","score":0.7350000143051147},{"id":"https://openalex.org/keywords/hydrogenation-kinetics","display_name":"hydrogenation kinetics","score":0.9779999852180481},{"id":"https://openalex.org/keywords/process-optimization","display_name":"process optimization","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C2780828025","wikidata":"https://www.wikidata.org/wiki/Q44793182","display_name":"Fluoride","level":2,"score":0.8068250417709351},{"id":"https://openalex.org/C2776641247","wikidata":"https://www.wikidata.org/wiki/Q2468","display_name":"Hydrogen fluoride","level":2,"score":0.7070431113243103},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6265268325805664},{"id":"https://openalex.org/C512968161","wikidata":"https://www.wikidata.org/wiki/Q556","display_name":"Hydrogen","level":2,"score":0.6258615851402283},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.5840163230895996},{"id":"https://openalex.org/C55766333","wikidata":"https://www.wikidata.org/wiki/Q11136680","display_name":"Inert gas","level":2,"score":0.5285778641700745},{"id":"https://openalex.org/C111335779","wikidata":"https://www.wikidata.org/wiki/Q3454686","display_name":"Reduction (mathematics)","level":2,"score":0.4858095645904541},{"id":"https://openalex.org/C154256306","wikidata":"https://www.wikidata.org/wiki/Q41795528","display_name":"Inert","level":2,"score":0.4834657311439514},{"id":"https://openalex.org/C148898269","wikidata":"https://www.wikidata.org/wiki/Q1108792","display_name":"Kinetics","level":2,"score":0.4652484357357025},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.39973706007003784},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.3027215301990509},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2959133982658386},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.oprd.2c00323","doi":"https://doi.org/10.1021/acs.oprd.2c00323","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.2c00323","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1973896181","https://openalex.org/W2005440005","https://openalex.org/W2043360909","https://openalex.org/W2074075725","https://openalex.org/W2074963833","https://openalex.org/W2079616106","https://openalex.org/W2097163271","https://openalex.org/W2156796649","https://openalex.org/W2505323176","https://openalex.org/W2790045560","https://openalex.org/W2792578296","https://openalex.org/W2889447070","https://openalex.org/W2919872217","https://openalex.org/W2978997040","https://openalex.org/W4210657807"],"related_works":["https://openalex.org/W4327694652","https://openalex.org/W3005144846","https://openalex.org/W1897536682","https://openalex.org/W4392602926","https://openalex.org/W2026926592","https://openalex.org/W2328240097","https://openalex.org/W3025914957","https://openalex.org/W2040852425","https://openalex.org/W3199190479","https://openalex.org/W2381611610"],"abstract_inverted_index":{"A":[0],"nitroarene":[1],"reduction":[2],"process":[3],"was":[4],"developed":[5],"to":[6,15,63],"run":[7],"on":[8,57],"a":[9],"multi-kilo":[10],"scale":[11,59],"with":[12,67],"optimized":[13],"conditions":[14],"reduce":[16],"the":[17,35,38,41,61,65],"formation":[18],"of":[19,37,40,51],"hydrogen":[20,54],"fluoride":[21,55],"through":[22],"catalytic":[23],"hydrodefluorination":[24],"and":[25,32],"an":[26,48],"unanticipated":[27],"oxidative":[28],"pathway.":[29],"Process":[30],"understanding":[31],"optimization,":[33],"including":[34],"characterization":[36],"kinetics":[39],"hydrogenation,":[42],"are":[43],"disclosed":[44],"as":[45,47],"well":[46],"innovative":[49],"way":[50],"neutralizing":[52],"any":[53],"formed":[56],"plant":[58],"without":[60],"need":[62],"purge":[64],"vessel":[66],"inert":[68],"gas.":[69]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-01-06T00:00:00"}